Who can use Daxas(Roflumilast‌)?

DALIRESP is specifically approved to lower the frequency of symptom worsening episodes in a well-defined group of patients with severe COPD.

Indications for Use

DALIRESP is indicated to reduce the risk of exacerbations in patients with severe Chronic Obstructive Pulmonary Disease (COPD). Its use is specifically targeted at individuals whose COPD is associated with the chronic bronchitis phenotype and who have a history of experiencing these exacerbations. It is critical to note that this medication is not indicated for the relief of acute bronchospasm or for immediate rescue from sudden breathing problems. Its role is preventive and long-term, focusing on decreasing the rate of flare-ups rather than treating acute symptoms.